Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.02    -0.13 (-1.60%)
Bid:
7.85
Ask:
8.10
Spread: 0.25 (3.185%)
Market Cap: £92.69m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Pre Stabilisation Notice

2 Nov 2021 13:38

RNS Number : 1012R
HSBC Bank plc
02 November 2021
 

2nd November 2021

 

SIG plc 

Pre Stabilisation Notice

HSBC (contact: 'synd manager'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

SIG plc

Guarantor (if any):

na

Aggregate nominal amount:

EUR 300,000,000

Description:

Fixed 5yr

Offer price:

TBC

Other offer terms:

 

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

4th November 2021

Stabilisation period expected to end no later than:

10th December 2021

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFZMGMFZKGMZM
Date   Source Headline
3rd Jun 20263:50 pmRNSDirector/PDMR Shareholding
28th May 20262:56 pmRNSDirector/PDMR Shareholding
22nd May 20261:36 pmRNSDirector/PDMR Shareholding
22nd May 20261:29 pmRNSDirector/PDMR Shareholding
22nd May 20261:18 pmRNSResult of Meeting
20th May 20263:07 pmRNSDirector/PDMR Shareholding
14th May 20264:44 pmRNSDirector/PDMR Shareholding
13th May 20265:27 pmRNSDirector/PDMR Shareholding
6th May 202611:11 amRNSDirector/PDMR Shareholding
6th May 202610:24 amRNSNotice of GM
30th Apr 20262:00 pmRNSResult of AGM
30th Apr 20267:01 amRNSTrading Update
30th Apr 20267:00 amRNSAppointment of Chief Financial Officer
10th Apr 20267:00 amRNSDirectorate change
23rd Mar 202610:57 amRNSDirector/PDMR Shareholding
23rd Mar 20269:59 amRNSNotice of AGM
4th Mar 202610:18 amRNSAnnual Financial Report
4th Mar 20267:00 amRNSFull year results for year ended 31 December 2025
15th Jan 20264:02 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS2025 Full Year Trading Update & Strategy Framework
19th Dec 20257:00 amRNSNotice of Trading & Business Update
19th Dec 20257:00 amRNSNotice of Trading & Business Update
23rd Oct 202511:05 amRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSQ3 Trading Update
1st Oct 20259:00 amRNSDirector/PDMR Shareholding
3rd Sep 202510:54 amRNSHolding(s) in Company
28th Aug 20251:02 pmRNSResult of Meeting
8th Aug 202511:01 amRNSNotice of GM
5th Aug 20257:00 amRNSResults for the six months to 30 June 2025
8th Jul 20257:01 amRNSAppointment of CEO and Chair designate
8th Jul 20257:00 amRNSH1 Trading Update
9th May 20257:00 amRNSDirectorate Change
6th May 20253:00 pmRNSHolding(s) in Company
1st May 20253:12 pmRNSResult of AGM
30th Apr 20257:00 amRNSTrading Update
10th Apr 20254:02 pmRNSDirector/PDMR Shareholding
4th Apr 202511:10 amRNSDirector/PDMR Shareholding
1st Apr 20254:00 pmRNSHolding(s) in Company
28th Mar 20255:03 pmRNSDirector/PDMR Shareholding
28th Mar 20254:59 pmRNSDirector/PDMR Shareholding
24th Mar 202510:06 amRNSNotice of AGM
21st Mar 20254:44 pmRNSDirector/PDMR Shareholding
12th Mar 20259:06 amRNSDirector/PDMR Shareholding
12th Mar 20258:54 amRNSDirectorate Change
10th Mar 20258:32 amRNSDirector/PDMR Shareholding
5th Mar 202511:17 amRNSAnnual Financial Report
5th Mar 20257:00 amRNSFull year results for year ended 31 December 2024
4th Mar 202512:52 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSHolding(s) in Company
30th Jan 20255:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.